Average Co-Inventor Count = 11.86
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
2. Revolution Medicines, Inc. (9 from 35 patents)
3. Maze Therapeutics, Inc. (1 from 3 patents)
21 patents:
1. 12365688 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
2. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
3. 12187746 - C26-linked rapamycin analogs as mTOR inhibitors
4. 11814367 - Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereof
5. 11739093 - Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
6. 11702411 - Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
7. 11685749 - C26-linked rapamycin analogs as mTOR inhibitors
8. 11673901 - Polycyclic compounds as allosteric SHP2 inhibitors
9. 11661401 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
10. 10980889 - C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
11. 10968210 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
12. 10688082 - Aminopyrazine compounds with A2A antagonist properties
13. 10590090 - 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
14. 10519147 - Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels
15. 10221167 - Hydroxyalkylamine- and hydroxycycloalkylamine-substituted diamine-arylsulfonamide compounds with selective activity in voltage-gated sodium channels